Crossmark

miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment

Crossref DOI link: https://doi.org/10.1038/bjc.2017.256

Published Online: 2017-08-08

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Piatopoulou, Despina

Avgeris, Margaritis

Marmarinos, Antonios

Xagorari, Marieta

Baka, Margarita

Doganis, Dimitrios

Kossiva, Lydia

Scorilas, Andreas

Gourgiotis, Dimitrios
License Information

Text and Data Mining valid from 2017-08-08
More Information

Article History

Received: 24 April 2017

Revised: 4 July 2017

Accepted: 10 July 2017

First Online: 8 August 2017

Competing interests

: The authors declare no conflict of interest.